Search

everythinglearnresearchcommunity

for

Search:↓

The book is a comprehensive resource on hair disorders, but lacks information on some conditions.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

The book is a useful resource for healthcare providers working with hospitalized children but misses some important studies and detailed problem evaluations.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Nilotinib can cause skin issues like red bumps and hair loss.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

New psoriasis treatments are effective but come with side effects and risks.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Nanocarrier systems could improve hair loss treatments by delivering drugs more effectively.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

DNA nanostructures could be a cost-effective way to deliver cancer drugs with fewer side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.